Vadastuximab talirine

Vadastuximab talirine (SGN-CD33A, 33A) is an antibody-drug conjugate consisting of pyrrolobenzodiazepine dimers linked to a monoclonal antibody targeting CD33, which is expressed in the majority of acute myeloid leukemia (AML) patients.
Supplier Selleck Chemicals
Product # D4030
Sku # D4030-1mg
Pricing 1mg, $970.00
Feedback